Literature DB >> 10487628

Trends in cancer of the cervix uteri in Sweden following cytological screening.

R Bergström1, P Sparén, H O Adami.   

Abstract

Trends in cervical cancer incidence following the introduction of screening have mostly been studied using cross-sectional data and not analysed separately for squamous cell cancer and adenocarcinomas. Using Swedish nationwide data on incidence and mortality, we analysed trends during more than 3 decades and fitted Poisson-based age-period-cohort models, and also investigated whether screening has reduced the incidence of adenocarcinomas of the cervix. The incidence of reported cancer in situ increased rapidly during 1958-1967. Incidence rates of squamous cell cancer, fairly stable before 1968, decreased thereafter by 4-6% yearly in women aged 40-64, with a much smaller magnitude in younger and older women. An age-cohort model indicated a stable 70-75% reduction in incidence for women born 1940 and later compared with those born around 1923. The incidence of adenocarcinomas doubled during the 35-year study period. The mortality rate increased by 3.6% before 1968 and decreased by 4.0% yearly thereafter. Although a combination of organized and opportunistic screening can reduce the incidence of squamous cell cancer substantially, the incidence of adenocarcinomas appears uninfluenced by screening.

Entities:  

Mesh:

Year:  1999        PMID: 10487628      PMCID: PMC2374360          DOI: 10.1038/sj.bjc.6690666

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model.

Authors:  P Sasieni; J Adams
Journal:  BMJ       Date:  1999-05-08

2.  Accelerated decline in cervical cancer mortality in England and Wales.

Authors:  P Sasieni; J Cuzick; E Farmery
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

Review 3.  Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem.

Authors:  S K Kjaer; L A Brinton
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

Authors:  M Quinn; P Babb; J Jones; E Allen
Journal:  BMJ       Date:  1999-04-03

5.  The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon.

Authors:  T Zheng; T R Holford; Z Ma; Y Chen; W Liu; B A Ward; P Boyle
Journal:  Int J Epidemiol       Date:  1996-04       Impact factor: 7.196

6.  Recent cancer trends in the United States.

Authors:  S S Devesa; W J Blot; B J Stone; B A Miller; R E Tarone; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1995-02-01       Impact factor: 13.506

7.  Low efficiency of cytologic screening for cancer in situ of the cervix in older women.

Authors:  L Gustafsson; P Sparén; M Gustafsson; B Pettersson; E Wilander; R Bergström; H O Adami
Journal:  Int J Cancer       Date:  1995-12-11       Impact factor: 7.396

8.  Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.

Authors:  J E Macgregor; M K Campbell; E M Mann; K Y Swanson
Journal:  BMJ       Date:  1994-05-28

9.  Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.

Authors:  H Mitchell; G Medley; I Gordon; G Giles
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.

Authors:  L Gustafsson; P Sparén; M Gustafsson; E Wilander; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  41 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

2.  Age-incidence relationships and time trends in cervical cancer in Sweden.

Authors:  K Hemminki; X Li; P Mutanen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.

Authors:  S Liu; R Semenciw; Y Mao
Journal:  CMAJ       Date:  2001-04-17       Impact factor: 8.262

4.  Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.

Authors:  Yevgeniy S Karamurzin; Takako Kiyokawa; Vinita Parkash; Anjali R Jotwani; Prusha Patel; Malcolm C Pike; Robert A Soslow; Kay J Park
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

5.  Prospective study of human papillomavirus and risk of cervical adenocarcinoma.

Authors:  Lisen Arnheim Dahlström; Nathalie Ylitalo; Karin Sundström; Juni Palmgren; Alexander Ploner; Sandra Eloranta; Carani B Sanjeevi; Sonia Andersson; Thomas Rohan; Joakim Dillner; Hans-Olov Adami; Pär Sparén
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

6.  The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas.

Authors:  S Andersson; A-C Hellström; Zhi-Ping Ren; E Wilander
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

7.  Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.

Authors:  Maria Grandahl; Tanja Tydén; Maria Gottvall; Ragnar Westerling; Marie Oscarsson
Journal:  Health Expect       Date:  2012-12-16       Impact factor: 3.377

8.  The frequency of Pap smear screening in the United States.

Authors:  Brenda E Sirovich; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

9.  Major clinical research advances in gynecologic cancer 2009.

Authors:  Kidong Kim; Sang-Young Ryu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

10.  Self-sampling of the vaginal fluid at home combined with high-risk HPV testing.

Authors:  K Sanner; I Wikström; A Strand; M Lindell; E Wilander
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.